Comparison of efficacy and persistence of first line fingolimod vs interferon-beta/glatiramer in the presence of prior disease activity

Tim Spelman; G Izquierdo; Raed Alroughani; R Fernandez-Bolanos; E Havrdova; D Horaova; C Oreja-Guevara; Jeannette Lechner-Scott; Mark Slee; M Barnett; C. Boz; M Terzi; F Grand'Maison; A Lugaresi; M Trojano; H Butzkueven; MSBase Study Group

doi:10.1177/1352458515602642

Comparison of efficacy and persistence of first line fingolimod vs interferon-beta/glatiramer in the presence of prior disease activity

Tim Spelman, G Izquierdo, Raed Alroughani, R Fernandez-Bolanos, E Havrdova, D Horaova, C Oreja-Guevara, Jeannette Lechner-Scott, Mark Slee, M Barnett, C. Boz, M Terzi, F Grand'Maison, A Lugaresi, M Trojano, H Butzkueven, MSBase Study Group

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	237-238
Number of pages	2
Journal	Multiple Sclerosis
Volume	21
Issue number	Supp: 11
DOIs	https://doi.org/10.1177/1352458515602642
Publication status	Published - Sept 2015
Event	31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis - Barcelona, Spain Duration: 7 Oct 2015 → 10 Oct 2015 Conference number: 31

Access to Document

10.1177/1352458515602642Licence: In Copyright

Cite this

Spelman, T., Izquierdo, G., Alroughani, R., Fernandez-Bolanos, R., Havrdova, E., Horaova, D., Oreja-Guevara, C., Lechner-Scott, J., Slee, M., Barnett, M., Boz, C., Terzi, M., Grand'Maison, F., Lugaresi, A., Trojano, M., Butzkueven, H., & MSBase Study Group (2015). Comparison of efficacy and persistence of first line fingolimod vs interferon-beta/glatiramer in the presence of prior disease activity. Multiple Sclerosis, 21(Supp: 11), 237-238. https://doi.org/10.1177/1352458515602642

@article{5a00417ac15548158e1f25ee67b77c6c,

title = "Comparison of efficacy and persistence of first line fingolimod vs interferon-beta/glatiramer in the presence of prior disease activity",

author = "Tim Spelman and G Izquierdo and Raed Alroughani and R Fernandez-Bolanos and E Havrdova and D Horaova and C Oreja-Guevara and Jeannette Lechner-Scott and Mark Slee and M Barnett and C. Boz and M Terzi and F Grand'Maison and A Lugaresi and M Trojano and H Butzkueven and {MSBase Study Group}",

year = "2015",

month = sep,

doi = "10.1177/1352458515602642",

language = "English",

volume = "21",

pages = "237--238",

journal = "Multiple Sclerosis",

issn = "1352-4585",

publisher = "SAGE Publications Ltd",

number = "Supp: 11",

note = "31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis, ECTRIMS ; Conference date: 07-10-2015 Through 10-10-2015",

}

Spelman, T, Izquierdo, G, Alroughani, R, Fernandez-Bolanos, R, Havrdova, E, Horaova, D, Oreja-Guevara, C, Lechner-Scott, J, Slee, M, Barnett, M, Boz, C, Terzi, M, Grand'Maison, F, Lugaresi, A, Trojano, M, Butzkueven, H & MSBase Study Group 2015, 'Comparison of efficacy and persistence of first line fingolimod vs interferon-beta/glatiramer in the presence of prior disease activity', Multiple Sclerosis, vol. 21, no. Supp: 11, pp. 237-238. https://doi.org/10.1177/1352458515602642

TY - JOUR

T1 - Comparison of efficacy and persistence of first line fingolimod vs interferon-beta/glatiramer in the presence of prior disease activity

AU - Spelman, Tim

AU - Izquierdo, G

AU - Alroughani, Raed

AU - Fernandez-Bolanos, R

AU - Havrdova, E

AU - Horaova, D

AU - Oreja-Guevara, C

AU - Lechner-Scott, Jeannette

AU - Slee, Mark

AU - Barnett, M

AU - Boz, C.

AU - Terzi, M

AU - Grand'Maison, F

AU - Lugaresi, A

AU - Trojano, M

AU - Butzkueven, H

AU - MSBase Study Group

N1 - Conference code: 31

PY - 2015/9

Y1 - 2015/9

UR - http://journals.sagepub.com/doi/pdf/10.1177/1352458515602642

U2 - 10.1177/1352458515602642

DO - 10.1177/1352458515602642

M3 - Meeting Abstract

SN - 1352-4585

VL - 21

SP - 237

EP - 238

JO - Multiple Sclerosis

JF - Multiple Sclerosis

IS - Supp: 11

T2 - 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis

Y2 - 7 October 2015 through 10 October 2015

ER -

Comparison of efficacy and persistence of first line fingolimod vs interferon-beta/glatiramer in the presence of prior disease activity

Access to Document

Other files and links

Cite this